Literature DB >> 11531266

Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2.

D Darmoul1, J C Marie, H Devaud, V Gratio, M Laburthe.   

Abstract

The protease-activated receptor-2 (PAR-2) is a G protein-coupled receptor that is cleaved and activated by trypsin. We investigated the expression of PAR-2 and the role of trypsin in cell proliferation in human colon cancer cell lines. A total of 10 cell lines were tested for expression of PAR-2 mRNA by Northern blot and RT-PCR. PAR-2 protein was detected by immunofluorescence. Trypsin and the peptide agonist SLIGKV (AP2) were tested for their ability to induce calcium mobilization and to promote cell proliferation on serum-deprived cells. PAR-2 mRNA was detected by Northern blot analysis in 6 out of 10 cell lines [HT-29, Cl.19A, Caco-2, SW480, HCT-8 and T84]. Other cell lines expressed low levels of transcripts, which were detected only by RT-PCR. Further results were obtained with HT-29 cells: (1) PAR-2 protein is expressed at the cell surface; (2) an increase in intracellular calcium concentration was observed upon trypsin (1-100 nM) or AP2 (10-100 microM) challenges; (3) cells grown in serum-deprived media supplemented with trypsin (0.1-1 nM) or AP2 (1-300 microM) exhibited important mitogenic responses (3-fold increase of cell number). Proliferative effects of trypsin or AP2 were also observed in other cell lines expressing PAR-2. These data show that subnanomolar concentrations of trypsin, acting at PAR-2, promoted the proliferation of human colon cancer cells. The results of this study indicate that trypsin could be considered as a growth factor and unravel a new mechanism whereby serine proteases control colon tumours. Copyright 2001 Cancer Research Compaign http://www.bjcancer.com Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11531266      PMCID: PMC2364111          DOI: 10.1054/bjoc.2001.1976

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  55 in total

Review 1.  Review article: proteinase-activated receptors - novel signals for gastrointestinal pathophysiology.

Authors:  N Vergnolle
Journal:  Aliment Pharmacol Ther       Date:  2000-03       Impact factor: 8.171

Review 2.  Protease activated receptors: theme and variations.

Authors:  P J O'Brien; M Molino; M Kahn; L F Brass
Journal:  Oncogene       Date:  2001-03-26       Impact factor: 9.867

3.  Effect of proteases on activation of resting chick embryo fibroblasts and on cell surface proteins.

Authors:  P M Blumberg; P W Robbins
Journal:  Cell       Date:  1975-10       Impact factor: 41.582

4.  Marked increase of trypsin(ogen) in serum of linitis plastica (gastric cancer, borrmann 4) patients.

Authors:  Y Ichikawa; N Koshikawa; S Hasegawa; T Ishikawa; N Momiyama; C Kunizaki; M Takahashi; Y Moriwaki; H Akiyama; H Yamaoka; S Yanoma; A Tsuburaya; Y Nagashima; H Shimada; K Miyazaki
Journal:  Clin Cancer Res       Date:  2000-04       Impact factor: 12.531

Review 5.  Matrix metalloproteinases: multifunctional contributors to tumor progression.

Authors:  L J McCawley; L M Matrisian
Journal:  Mol Med Today       Date:  2000-04

6.  Initiation of check cell division by trypsin action at the cell surface.

Authors:  D H Carney; D D Cunningham
Journal:  Nature       Date:  1977-08-18       Impact factor: 49.962

7.  Serum trypsinogen-2 and trypsin-2-alpha(1)-antitrypsin complex in malignant and benign digestive-tract diseases. Preferential elevation in patients with cholangiocarcinomas.

Authors:  J Hedström; C Haglund; R Haapiainen; U H Stenman
Journal:  Int J Cancer       Date:  1996-05-03       Impact factor: 7.396

8.  Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM.

Authors:  P Singh; M Velasco; R Given; M Wargovich; A Varro; T C Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-03       Impact factor: 4.052

9.  Evidence for the activation of PAR-2 by the sperm protease, acrosin: expression of the receptor on oocytes.

Authors:  R Smith; A Jenkins; A Lourbakos; P Thompson; V Ramakrishnan; J Tomlinson; U Deshpande; D A Johnson; R Jones; E J Mackie; R N Pike
Journal:  FEBS Lett       Date:  2000-11-10       Impact factor: 4.124

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  38 in total

Review 1.  Clinical relevance of proteinase activated receptors (pars) in the gut.

Authors:  N Vergnolle
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

2.  Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation.

Authors:  Roberta Caruso; Francesco Pallone; Daniele Fina; Valentina Gioia; Ilaria Peluso; Flavio Caprioli; Carmine Stolfi; Alessandra Perfetti; Luigi Giusto Spagnoli; Giampiero Palmieri; Thomas T Macdonald; Giovanni Monteleone
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

3.  Best practices for naming, receiving, and managing cells in culture.

Authors:  Yvonne A Reid
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-10-06       Impact factor: 2.416

Review 4.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

Review 5.  The orexin receptor OX(1)R in colon cancer: a promising therapeutic target and a new paradigm in G protein-coupled receptor signalling through ITIMs.

Authors:  Marc Laburthe; Thierry Voisin
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

6.  Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells.

Authors:  Dalila Darmoul; Valérie Gratio; Hélène Devaud; Thérèse Lehy; Marc Laburthe
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

7.  Protease-activated receptors in cancer: A systematic review.

Authors:  Na Han; Ketao Jin; Kuifeng He; Jiang Cao; Lisong Teng
Journal:  Oncol Lett       Date:  2011-04-08       Impact factor: 2.967

8.  Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells.

Authors:  Valérie Gratio; Nathalie Beaufort; Lina Seiz; Josefine Maier; G Duke Virca; Mekdes Debela; Nicolai Grebenchtchikov; Viktor Magdolen; Dalila Darmoul
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

9.  Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells.

Authors:  Paula M Maloberti; Alejandra B Duarte; Ulises D Orlando; María E Pasqualini; Angela R Solano; Carlos López-Otín; Ernesto J Podestá
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

Review 10.  Modulation of visceral pain and inflammation by protease-activated receptors.

Authors:  Nathalie Vergnolle
Journal:  Br J Pharmacol       Date:  2004-03-29       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.